Charles Schwab Portfolio holdings
Charles Schwab Corporation, founded in 1971 by Charles R. Schwab and headquartered in Westlake, Texas, is a leading financial services firm that revolutionized retail investing by offering low-cost brokerage services. Initially disrupting the industry with discount commissions, it has grown into a powerhouse providing a wide array of services, including trading platforms, robo-advisors, retirement accounts, and banking products, managing hundreds of billions in client assets. Known for its user-friendly technology and customer-centric approach, Schwab caters to individual investors, financial advisors, and institutions, notably expanding through its 2020 acquisition of TD Ameritrade. With a mission to democratize investing, Charles Schwab remains a dominant force in the shift toward accessible, self-directed wealth management.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street Technology Select Sector SPDR ETF
XLK
|
+$304M |
| 2 |
iShares 1-3 Year Treasury Bond ETF
SHY
|
+$189M |
| 3 |
AbbVie
ABBV
|
+$185M |
| 4 |
JPMorgan Ultra-Short Income ETF
JPST
|
+$176M |
| 5 |
iShares US Treasury Bond ETF
GOVT
|
+$174M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Broadcom
AVGO
|
+$430M |
| 2 |
Vanguard High Dividend Yield ETF
VYM
|
+$400M |
| 3 |
iShares 7-10 Year Treasury Bond ETF
IEF
|
+$374M |
| 4 |
iShares 0-1 Year Treasury Bond ETF
SHV
|
+$361M |
| 5 |
Invesco Actively Managed Exch-Traded Commodity Fd Tr Invesco Optimum Yield Diversified Commodity Strategy No K-1 ETF
PDBC
|
+$154M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 22.95% |
| 2 | Healthcare | 12.56% |
| 3 | Financials | 11.62% |
| 4 | Consumer Discretionary | 10.14% |
| 5 | Industrials | 9.69% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2526
Atea Pharmaceuticals
AVIR
$376M
| $2.15M | ﹤0.01% |
573,959
+47,610
| +9% | +$178K |
|
2527
Blink Charging
BLNK
$74.3M
| $2.14M | ﹤0.01% |
357,869
+15,321
| +4% | +$106K |
|
|
STER
2528
DELISTED
Sterling Check Corp. Common Stock
STER
| $2.14M | ﹤0.01% |
174,635
+1,403
| +0.8% | +$16.8K |
|
|
NVTA
2529
DELISTED
Invitae Corporation
NVTA
| $2.14M | ﹤0.01% |
1,893,538
+378,831
| +25% | +$478K |
|
|
CNH
2530
CNH Industrial
CNH
$12.7B
| $2.13M | ﹤0.01% |
+147,838
| New | +$2.08M |
|
2531
Waterstone Financial
WSBF
$370M
| $2.12M | ﹤0.01% |
146,315
-4,188
| -3% | -$59.8K |
|
2532
Stagwell
STGW
$2.09B
| $2.12M | ﹤0.01% |
293,646
+74,749
| +34% | +$494K |
|
|
GBIO
2533
DELISTED
Generation Bio
GBIO
| $2.11M | ﹤0.01% |
38,352
+4,997
| +15% | +$229K |
|
2534
Bank First Corp
BFC
$1.69B
| $2.1M | ﹤0.01% |
25,298
+4,447
| +21% | +$333K |
|
2535
ADMA Biologics
ADMA
$1.96B
| $2.1M | ﹤0.01% |
569,453
+7,231
| +1% | +$26.8K |
|
2536
FLEX LNG
FLNG
$1.69B
| $2.09M | ﹤0.01% |
68,572
+2,909
| +4% | +$93.1K |
|
2537
Seneca Foods Class A
SENEA
$1.12B
| $2.08M | ﹤0.01% |
63,684
+26,264
| +70% | +$1.24M |
|
|
EGRX
2538
DELISTED
Eagle Pharmaceuticals, Inc.
EGRX
| $2.07M | ﹤0.01% |
106,675
-1,454
| -1% | -$34.5K |
|
2539
MINISO
MNSO
$3.88B
| $2.07M | ﹤0.01% |
121,759
-1,715
| -1% | -$28.6K |
|
2540
Prime Medicine
PRME
$527M
| $2.07M | ﹤0.01% |
141,144
+67,717
| +92% | +$945K |
|
2541
IMAX
IMAX
$2.62B
| $2.07M | ﹤0.01% |
121,701
+14,238
| +13% | +$270K |
|
|
LL
2542
DELISTED
LL Flooring Holdings, Inc.
LL
| $2.05M | ﹤0.01% |
534,805
+172,244
| +48% | +$666K |
|
2543
Genie Energy
GNE
$367M
| $2.05M | ﹤0.01% |
144,626
+45,191
| +45% | +$669K |
|
2544
ANI Pharmaceuticals
ANIP
$1.8B
| $2.04M | ﹤0.01% |
37,974
+2,935
| +8% | +$130K |
|
2545
RxSight
RXST
$249M
| $2.04M | ﹤0.01% |
70,931
+10,155
| +17% | +$226K |
|
2546
Tucows
TCX
$172M
| $2.04M | ﹤0.01% |
73,369
-88
| -0.1% | -$2.27K |
|
2547
Toyota
TM
$224B
| $2.01M | ﹤0.01% |
12,513
+7,039
| +129% | +$1.01M |
|
2548
Cullinan Oncology
CGEM
$1.01B
| $2M | ﹤0.01% |
185,786
-1,747
| -0.9% | -$18.6K |
|
2549
RLX Technology
RLX
$2.47B
| $1.99M | ﹤0.01% |
1,125,266
+124,845
| +12% | +$279K |
|
2550
Microvast
MVST
$269M
| $1.98M | ﹤0.01% |
1,238,375
+43,339
| +4% | +$61.8K |
|
Similar funds
Charles Schwab's Q2 2023 Portfolio in Review
As of Q2 2023, Charles Schwab held 3,760 positions worth $350B, up 6.4% from $329B the previous quarter. Its ten largest holdings account for 19% of the portfolio.
Charles Schwab's Q2 2023 filing shows 210 new, 2,215 increased, 1,001 reduced and 151 closed positions. Its largest new stake was iShares US Treasury Bond ETF: 7,510,883 shares worth $172M. The largest sale was Broadcom, an estimated $430M.
By sector, the portfolio is most concentrated in Technology at 23% of assets, up from 21% a quarter earlier, followed by Healthcare and Financials.
- Charles Schwab's largest Q2 2023 buy was iShares US Treasury Bond ETF: 7,510,883 shares worth $172M.
- Charles Schwab added most to State Street Technology Select Sector SPDR ETF in Q2 2023, an estimated $304M increase.
- Charles Schwab's biggest Q2 2023 reduction was Broadcom, cutting an estimated $430M.
- Charles Schwab fully exited iShares 0-1 Year Treasury Bond ETF in Q2 2023, selling an estimated $361M.
- Charles Schwab's ten largest holdings make up 19% of its $350B portfolio in Q2 2023.
- Charles Schwab opened 210 new positions and closed 151 in Q2 2023.
- Charles Schwab's portfolio value rose 6.4% quarter-over-quarter to $350B.
Based on Charles Schwab's 13F filing for Q2 2023, filed 10 Aug 2023.